HPLC测定植物性农药——0.25%乌头总碱乳油中的乌头类生物碱

 选择十八烷基键合相柱 ,以甲醇 水 氯仿 三乙胺 (体积比为 6 8∶32∶2∶0 1)混合溶液为流动相 ,用高效液相法测定了一种植物性农药 0 2 5 %乌头总碱乳油中的乌头生物碱。实验结果表明中乌头碱、乌头碱及次乌头碱与其他杂质能够得到很好的分离。以安宫黄体酮作内标物 ,用峰面积比测定各生物碱含量 ,在其线性范围内分析结果准确 ,回收率高 (>92 % ) ,重现性好 (RSD <3 2 % ) 。     

高效毛细管电泳地测定中草药川乌,草乌中乌头碱的含量

建立了测定有毒中草药川乌和草乌中３种乌头碱的高效毛细管电泳方法,系统地考察了电泳条件对分离的影响,并应用于香港市售川乌及草乌中中乌头碱、次乌头碱和乌头碱的测定,检测限为１．６７－２．３１ｍｇ／Ｌ,回收率为９３．０－１０４．０％,相对标准差为０．６８－１．７０％。     

高效毛细管电泳法测定中草药川乌、草乌中乌头碱的含量

建立了测定有毒中草药川乌和草乌中３种乌头碱的高效毛细管电泳方法,系统地考察了电泳条件对分离的影响,并应用于香港市售川乌及草乌中中乌头碱、次乌头碱和乌头碱的测定。检测限为１．６７～２．３１ｍｇ／Ｌ,回收率为９３．０％～１０４．０％,相对标准偏差为０．６８％～１．７０％。     

超高效液相色谱-串联质谱法同时测定尿样中4种痕量的乌头类生物碱

建立了超高效液相色谱-串联质谱(UPLC-MS/MS)结合中空纤维微萃取(HF-LPME)同时检测尿样中痕量的乌头碱、次乌头碱、新乌头碱和滇乌头碱等4种生物碱的方法。采用HF-LPME对尿样进行提取、纯化和富集,富集倍数达102～301。同时采用电喷雾电离(ESI)、多反应监测(MRM)进行含量测定,显著提高了尿液中乌头类生物碱的检测灵敏度,4种乌头类生物碱的定量限达到0.01～0.1 ng/L,可大大延长中毒患者尿样中乌头类生物碱的检测时间窗。方法验证结果表明,尿液中乌头碱、新乌头碱和滇乌头碱在0.01～10 ng/L、次乌头碱在0.1～100 ng/L范围内线性关系良好,提取回收率为80.2%～109%,相对标准偏差小于4.6%。该方法适用于乌头类生物碱中毒案件的检测,为痕量乌头类生物碱分析提供了灵敏的分析方法。     

短距乌头根的生物碱成分.Ⅰ

从短距乌头(Aconitum brevicalcaratum Diels)的根中分得六个二萜生物碱成分,其中三个为新成分,即短距乌碱甲(acobretine A,1),短距乌碱乙(acobretine B,2)和短距乌碱丙(acobretine C,3).另三个为已知成分:花葶乌头宁(scaconine,4),花葶乌头碱(scaconitine,5)和N-脱乙酰花葶乌头碱(N-deacetylscaconitine,6).经IR,MS,^1H NMR,^1^3C NMR测定和化学方法确定可1～3的结构     

刺乌头碱氢溴酸盐的合成及晶体结构

报道了以双溴代烷烃和刺乌头碱合成刺乌头碱氢溴酸盐的方法. 用元素分析、红外光谱、高分辨质谱和核磁共振进行了表征. 并用X射线单晶衍射确定了标题化合物的绝对构型. 晶体结构表明, 该化合物通过分子间氢键形成了网状类似超分子结构. 晶体属于单斜晶系, P2₁空间群, 晶胞参数: a＝1.0619(2) nm, b＝1.2196(3) nm, c＝1.2282(2) nm, β＝90.87(1)°, V＝1.59037(54) nm³, Z＝2, D_m＝1.428 g/cm^－3, F(000)＝720.0, µ＝1.349 mm^－1. 环 A, B, C, D, E和F分别呈船式、椅式、信封式、船式、船式和信封式. 其绝对构型被确定为1S,4S,5S,7S,8S,9S,10S,11S,13R,14S,16S,17R.     

柱切换液相色谱法快速定量检测参附注射液中乌头碱类生物碱和人参皂苷

利用柱切换液相色谱,建立了参附注射液中苯甲酰新乌头原碱、苯甲酰乌头原碱、苯甲酰次乌头原碱、新乌头碱、次乌头碱和乌头碱6种乌头碱类生物碱,以及Rg1、Re、Rf、Rb1、Rc、Ro、Rb2、Rb3、Rd 9种人参皂苷的分析方法。首先利用强阳离子交换的在线固相小柱选择性富集和净化样品中生物碱类成分,优化了色谱条件;并采用EC－C18柱作为人参皂苷的分析柱,通过优化实验条件,结合柱切换方式,去除了样品中辅料等大极性基质成分对色谱柱的污染,实现了生物碱分析和人参皂苷分析的自动切换。结果显示,样品中的生物碱和人参皂苷分离良好,线性相关系数（r2）均大于0.999,连续进样精密度的相对标准偏差（RSD） < 2.0%,重复性的RSD < 2.0%;其中6种生物碱的平均回收率为95.1%～98.6%,检出限为4.0～8.2 ng/mL;9种人参皂苷的平均回收率为91.7%～104%。所构建的基于柱切换液相色谱技术的在线固相萃取方法能够有效去除样品中的基质干扰,快速完成参附注射液中3种单酯型生物碱和9种人参皂苷的快速定量,同时也可对3种双酯型生物碱进行限量检测,可应用于药物的质量评价。     

利用软电离质谱技术研究乌头碱在肠内细菌中的生物转化

采用人肠内细菌和乌头碱温孵的方法及电喷雾质谱技术, 探讨了乌头碱在人肠内的生物转化规律. 根据在正离子电喷雾电离条件下乌头类生物碱质子化分子[M+H]+提供的分子量信息, 并结合精确质量测定提供的元素组成及串联质谱提供的结构信息, 可以对乌头碱的转化产物直接进行定性分析. 研究结果表明, 乌头碱在人肠内细菌环境中可通过脱乙酰基、脱甲基、脱羟基以及酯化反应产生新型的单酯型、双酯型和脂类生物.     

16-O-去甲基乌头碱的生物转化及电喷雾质谱研究

采用乌头碱和人肠内细菌体外温孵的方法, 探讨乌头碱在肠内的生物转化规律. 乌头类生物碱在ESI正离子模式条件下形成质子化分子[M＋H]^＋, 利用离子阱电喷雾串联质谱和傅立叶离子回旋共振电喷雾串联质谱方法可以直接分析乌头碱的转化产物. 本文首次报道了乌头碱在人肠内菌群环境中产生16-O-去甲基乌头碱, 16-O-去甲基乌头碱可进一步被肠内细菌转化, 通过脱乙酰基、脱苯甲酰基、脱甲基、脱羟基以及酯化反应, 产生新型的单酯型、双酯型和20余种脂类生物碱等转化产物.     

乌头碱的代谢产物去氧乌头碱的生物转化及其电喷雾串联质谱

采用人肠内细菌和乌头碱体外温孵的方法, 探讨去氧乌头碱在人肠内的生物转化. 利用离子阱和傅里叶变换离子回旋共振质谱直接分析去氧乌头碱的转化产物. 乌头类生物碱及其代谢产物在正离子电喷雾质谱条件下形成质子化分子([M+H]+), 通过多级串联质谱进行结构表征. 去氧乌头碱可被人肠内细菌转化, 通过脱酰基、脱甲基脱羟基以及酯化反应产生新型的单酯型、双酯型和脂类生物碱等10余种代谢产物. 双酯型的去氧乌头碱的毒性较高, 当它被肠内细菌转化为单酯型和脂类生物碱时会使其毒性降低.     

Novel Product and Its Derivatives from the Reaction of Lappaconitine with HIO_4

Lappaconitine l, a bisnorditerpenoid alkaloid, was isolated from many plants ofAconitum and Delphinium species such as A. barbatum var. puberulum, A.sinomontanuml' 2. It is now used in the clinical practice as an analgesic in China', andantiarrhythmic drugs in Uzbekistan4' 5. In our attempts to prepare the 10-oxygenatedderivatives by treating lappaconitine I with HIO. followed by bromination, unexpectedby-products were obtained in modest yields. This communication described the isolationan…     

NaIO_4-Catalyzed Bromination of the Aromatic Ring of Lappaconitine

Lappaconitine 1, a bisnorditerpenoid alkaloid, was isolated from many plants of Aconitum species such as A. barbatum var. pulerulum and A. sinomontanum (Ranunculaceae)1-3, and used clinically for treatment of analgic disease as a nonaddicted drug in China4, and as an antiarrythmic in Uzbekistan5. In order to search for high activity, low toxicity compounds, we have carried out the structure modifications of lappaconitine. In this case, an attempt to induce the oxygenated group at C-10 in 1 b…     

Studies on the metabolism of lappaconitine in humans. Identification of the metabolites of lappaconitine in human urine by high performance liquid chromatography

The metabolites of lappaconitine in the urine of humans having been previously administered intramuscularly with lappaconitine hydrobromide were studied using high performance liquid chromatography with electrochemical and ultraviolet detection. The urine was extracted by means of liquid- and solid-phase extractions. Each of the metabolites of lappaconitine was purified by high performance liquid chromatography on a reversed phase column and identified on the basis of the chromatographic behaviour and the detector response. It was proved that lappaconitine, N-deacetyl-16-O-demethyllappaconitine and N-deacetyllappaconitine were excreted in urine from humans receiving lappaconitine.     

Method of obtaining allapinine from the epigeal part of Aconitum leucostomum

The industrial processes for obtaining allapinine (lappaconitine hydrobromide) from the epigeal part ofAconitum leucostomum have been studied. As a result, a rational method of obtaining allapinine from the plant raw material has been developed which consists in the extraction of the raw material with 80% ethanol and concentration to an aqueous residue, followed by extraction with chloroform, purification, the production of technical allapinine, and its recrystallization from methanol or from aqueous ethanol. The yield of allapinine satisfying the requirements of VFS 31-1667-86 amounts to 72–80% of its amount in the raw material.Institute of the Chemistry of Plant Substances, Academy of Sciences of the Uzbek SSR, Tashkent. Translated from Khimiya Prirodnykh Soedinenii, No. 1, pp. 91–94, January–February, 1988.     

Study of alkaloids of the Siberian and Altai flora. 10. Synthesis of N(20)-deethyllappaconitine derivatives

Efficient procedures were developed for N-deethylation of lappaconitine to give N(20)-deethyllappaconitine. Alkyl derivatives of N(20)-deethyllappaconitine, including labeled lappaconitine, and N(20)-acetoxy-N(20)-deethyllappaconitine were prepared for the first time. The assignments of the signals for the carbon atoms in the ¹³C NMR spectra of lappaconitine and related lappaconine were refined using ¹³C—¹³C 2D INADEQUATE and 2D ¹³C—¹H correlation experiments.     

Isolation of lappaconitine from Aconitum septentrionale roots by adsorption

Extracts of Aconitum septentrionale Koelle roots obtained using chloroform, isopropanol, and ethanol were purified using chloroform and basic γ-Al₂O₃. Ballast materials were selectively adsorbed by γ-Al₂O₃, increasing the mass fraction of lappaconitine in the extract. The ethanol extract was purified most. The degree of lappaconitine extraction by chloroform was unaffected by the presence of γ-Al₂O₃. However, the mass fraction in the extract and lappaconitine extraction from Aconitum septentrionale were increased more than twice. __________ Translated from Khimiya Prirodnykh Soedinenii, No. 3, pp. 274–276, May–June, 2006.     

Redox reactions of natural alkaloid lappaconitine

A review on redox reactions of natural alkaloid lappaconitine, a known sodium channel blocker, is presented. The NMR and CIDNP data on the mechanism of phototransformation of lappaconitine, in particular, of its paramagnetic species formed by both the direct photolysis and photoinitiated interaction with electron donors and acceptors, are analyzed. Special attention is given to the interaction of lappaconitine with amino acids, which are present in the active site of the sodium channel. Hypotheses about a relationship between this process and the mechanism of therapeutic activity of lappaconitine are discussed. Published in Russian in Izvestiya Akademii Nauk. Seriya Khimicheskaya, No. 4, pp. 608–619, April, 2007.     

Application of high performance capillary electrophoresis on toxic alkaloids analysis

We employed CE to identify mixtures of the toxic alkaloids lappaconitine, bullatine A, atropine sulfate, atropine methobromide, scopolamine hydrobromide, anisodamine hydrobromide, brucine, strychnine, quinine sulfate, and chloroquine in human blood and urine, using procaine hydrochloride as an internal standard. The separation employed a fused-silica capillary of 75 microm id x 60 cm length (effective length: 50.2 cm) and a buffer containing 100 mM phosphate and 5% ACN (pH 4.0). The sample was injected in a pressure mode and the separation was performed at a voltage of 16 kV and a temperature of 25 degrees C. The compounds were detected by UV absorbance at wavelengths of 195 and 235 nm. All the ten alkaloids were separated within 16 min. The method was validated with regard to precision (RSD), accuracy, sensitivity, linear range, LOD, and LOQ. In blood and urine samples, the detection limits were 5-40 ng/mL and linear calibration curves were obtained over the range of 0.02-10 microg/mL. The precision of intra- and interday measurements was less than 15%. Electrophoretic peaks could be identified either by the relative migration time or by their UV spectrum.     

Separation and characterization of the metabolic products of lappaconitine in rat urine by high-performance liquid chromatography

The separation and characterization of the metabolic products of lappaconitine in rat urine by high-performance liquid chromatography with electrochemical and ultraviolet detection are described. Urine samples from rats intravenously administered lappaconitine hydrobromide were extracted with chloroform and then purified on a Sep-Pak C18 cartridge. The subsequent resolution into individual compounds was achieved by high-performance liquid chromatography. Identification of these compounds was based on comparisons of the chromatographic behaviour and the detector response with those of authentic samples. Changes in the ratio of lappaconitine to its metabolites in rat urine with time after dosing led to a proposal for one of the probable metabolic pathways of lappaconitine in the rat.